Observational studyDiabetes, obesity & metabolism2019

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study.

Anna Norhammar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.